Cód QR

Outcomes with chimeric antigen receptor t-cell therapy in relapsed or refractory acute myeloid leukemia: a systematic review and meta-analysis

BackgroundWe conducted a systematic review and meta-analysis to evaluate outcomes following chimeric antigen receptor T cell (CAR-T) therapy in relapsed/refractory acute myeloid leukemia (RR-AML).MethodsWe performed a literature search on PubMed, Cochrane Library, and Clinicaltrials.gov. After scree...

Cur síos iomlán

Sábháilte in:
Príomhchruthaitheoirí: Moazzam Shahzad, Andrea Nguyen, Ali Hussain, Mohammad Ammad-Ud-Din, Muhammad Salman Faisal, Ezza Tariq, Fatima Ali, Atif Butt, Iqra Anwar, Sibgha Gull Chaudhary, Forat Lutfi, Nausheen Ahmed, Anurag K. Singh, Peiman Hematti, Joseph P. McGuirk, Muhammad Umair Mushtaq
Formáid: Artigo
Teanga:Inglês
Foilsithe / Cruthaithe: Frontiers Media S.A. 2023-04-01
Sraith:Frontiers in Immunology
Ábhair:
acute myeloid leukemia
relapsed or refractory AML
chimeric antigen receptor T cell therapy
outcomes
immunotherapy
Rochtain ar líne:https://www.frontiersin.org/articles/10.3389/fimmu.2023.1152457/full
Clibeanna: Cuir clib leis
Níl clibeanna ann, Bí ar an gcéad duine le clib a chur leis an taifead seo!

Míreanna comhchosúla